In animal models, impaired TGF-β1 signaling has been considered a hallmark of early-stage AD brains as it contributes to microglial activation and neuronal cell cycle reactivation, which are both implicated in AD neurodegeneration [283]. The gene discussed is TGFB1; the disease is Alzheimer disease.